학술논문

Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials.
Document Type
Article
Source
Diabetes/Metabolism Research & Reviews; Feb2024, Vol. 40 Issue 2, p1-34, 34p
Subject
TYPE 2 diabetes
CLINICAL trials
DYSLIPIDEMIA
GUT microbiome
METABOLIC disorders
Language
ISSN
15207552
Abstract
Copyright of Diabetes/Metabolism Research & Reviews is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)